All In MedTech

Device Trial Radar · NCT06917339

Retrospective Analyses of TrakStar Database

Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes

Last checked: Nov 20, 2026Latest source record: Apr 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

156,000

Planned (sponsor's estimate)

Start

Feb 25, 2025

Primary completion

Dec 2035

Study completion Dec 2035

Sponsor

Lead sponsor
NeuroneticsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 8, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 5 years, up to 120 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

Conditions

  • Depression
  • Obsessive-Compulsive Disorder
  • Anxiety Depression

Interventions

  • NeuroStar Advanced TMS Therapy SystemDevice

    non-invasive brain stimulation device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in clinical assessment score from baseline to post-treatmentTime frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Neuronetics

    Malvern, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.